Joan S. Brugge
Affiliations: | Biology: Medical Sciences, Division of | Harvard University, Cambridge, MA, United States |
Area:
Cell Biology, General Biophysics, Biomechanics BiophysicsGoogle:
"Joan Brugge"Children
Sign in to add traineeBridget N. Queenan | research assistant | 2003 | Harvard Medical School (Neurotree) |
Maria A. Martinez Gakidis | grad student | 2003 | Harvard |
Kenna R. Mills | grad student | 2004 | Harvard |
Sarah E. Seton-Rogers | grad student | 2004 | Harvard |
Nicole L. Collins | grad student | 2006 | Harvard |
Melodie L. Knowlton | grad student | 2010 | Harvard |
Alexandra R. Grassian | grad student | 2011 | Harvard |
Alice S. Kaanta | grad student | 2012 | Harvard |
Mei R. Ng | grad student | 2012 | Harvard |
Rachel A. Davidowitz | grad student | 2013 | Harvard |
Zachary T. Schafer | post-doc | Harvard (Chemistry Tree) | |
Shengwen Li | post-doc | 1997-1998 | Harvard University (medical School) (Chemistry Tree) |
Mauricio J. Reginato | post-doc | 1998-2004 | Harvard Medical School (Cell Biology Tree) |
Jonathan A. kelber | research scientist | 2017-2017 | Harvard Medical School (Neurotree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gray GK, Girnius N, Kuiken HJ, et al. (2023) Single-cell and spatial analyses reveal a tradeoff between murine mammary proliferation and lineage programs associated with endocrine cues. Cell Reports. 42: 113293 |
Takahashi N, Cho P, Selfors LM, et al. (2020) 3D Culture Models with CRISPR Screens Reveal Hyperactive NRF2 as a Prerequisite for Spheroid Formation via Regulation of Proliferation and Ferroptosis. Molecular Cell |
Zervantonakis IK, Poskus MD, Scott AL, et al. (2020) Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways. Proceedings of the National Academy of Sciences of the United States of America |
Shu S, Wu HJ, Ge JY, et al. (2020) Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer. Molecular Cell |
Rosenbluth JM, Schackmann RCJ, Gray GK, et al. (2020) Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nature Communications. 11: 1711 |
Caswell-Jin JL, McNamara KL, Dering J, et al. (2020) Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US B07 trial Cancer Research. 80 |
Zoeller JJ, Vagodny A, Daniels VW, et al. (2020) Abstract P3-11-06: Pre-clinical assessment of combined ABT-263/Navitoclax and ABT-414 or ABBV-321 treatment for EGFR-expressing TNBC Cancer Research. 80 |
Shapiro HK, Li CM, Tsiobikas C, et al. (2020) Characterization of Mammary Cells Co‐expressing Separate Lineage Markers The Faseb Journal. 34: 1-1 |
Harris IS, Brugge JS. (2019) United They Stand, Divided They Fall. Cell Metabolism. 30: 624-625 |
Press MF, Xie B, Davenport S, et al. (2019) Role for polo-like kinase 4 in mediation of cytokinesis. Proceedings of the National Academy of Sciences of the United States of America |